Tandem Diabetes Care (NSDQ:TNDM) and Dexcom (NSDQ:DXCM) announced yesterday that the companies would extend their existing joint welcome program aimed at luring Animas customers as Johnson & Johnson (NYSE:JNJ) bails out of the insulin pump biz.
Tandem and Dexcom’s t:slim X2 welcome program was slated to end on Dec. 31, but the companies said yesterday that it would continue until the end of March next year.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem looks to get in on ex-Animas customer base appeared first on MassDevice.
from MassDevice http://ift.tt/2z6E8Nn
Cap comentari:
Publica un comentari a l'entrada